Cite
HARVARD Citation
Zeng, H. et al. (2014). AB0385 A Randomized Controlled Clinical TRIAL to Evaluate the Efficacy of Recombinant Human Tumor Necrosis Factor-α Receptor II Fusion Protein in Juvenile Idiopathic Arthritis. Annals of the rheumatic diseases. pp. 933-934. [Online].